Mylan Receives Approval for Generic Version of Mirapex

Mylan Inc. Thursday announced that its subsidiary Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application for Pramipexole Dihydrochloride Tablets, the generic version of Boehringer Ingelheim’s Mirapex.
iStockAnalyst